Biosite Countersues Roche In Dispute Over Diagnostic Test Patents
Biosite’s lawsuit, filed in the U.S. District Court for the Southern District of California, alleges that Roche Diagnostics Corp. and Roche Diagnostics GmbH are infringing two patents, U.S. Patent 6,174,686 and U.S. Patent 5,795,725, owned by Biosite.
The patents relate to methods for the measurement of cardiac troponin forms, according to Biosite.
Roche Diagnostics is a U.S. subsidiary of Swiss drug maker F....
To view the full article, register now.